Jean‐Vianney Haure‐Mirande

Author

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Haure-Mirande, Jean-Vianney, J-V Haure-Mirande, Jean Vianney Haure-Mirande, Jean-Vianney Haure-Mirande, Jean‐Vianney Haure‐Mirande, V. Haure-Mirande, Vianney Haure-Mirande, Vianney Haure‐Mirande

Publications

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai James J. Peters VA Medical Center Sema4 (United States)The King's College PhysioPathologie des Adaptations Nutritionnelles

About

Jean‐Vianney Haure‐Mirande is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, neurodegenerative diseases, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	792
2	Neuroscience	4	4	777
3	Neurology	3	3	741
4	Social Sciences	2	2	49
5	Gastroenterology	1	1	15

Jean‐Vianney Haure‐Mirande

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus Ben Readhead, Jean‐Vianney Haure‐Mirande, Cory C. Funk, Neuron Neurodegenerative DiseasesClinical NetworksAlzheimer's DiseaseMultiscale AnalysisNeurovirology	2018	708
Multiscale causal networks identify VGF as a key regulator of Alzheimer’s disease Noam D. Beckmann, Wei‐Jye Lin, Minghui Wang, Nature Communications	2020	181
Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology Jean‐Vianney Haure‐Mirande, Mickaël Audrain, Tomas Fanutza, Acta Neuropathologica	2017	123
Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden Jean‐Vianney Haure‐Mirande, Minghui Wang, Mickaël Audrain, Molecular Psychiatry	2018	93
Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau Mickaël Audrain, Jean‐Vianney Haure‐Mirande, Minghui Wang, Molecular Psychiatry	2018	73
Microglial <i>INPP5D</i> limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease Emilie L. Castranio, Philip Hasel, Jean‐Vianney Haure‐Mirande, Alzheimer s & Dementia	2022	68
Reactive or transgenic increase in microglial TYROBP reveals a TREM2‐independent TYROBP–APOE link in wild‐type and Alzheimer's‐related mice Mickaël Audrain, Jean‐Vianney Haure‐Mirande, Justyna Mleczko, Alzheimer s & Dementia	2020	59
Visceral adipose tissue and leptin increase colonic epithelial tight junction permeability <i>via</i> a RhoA‐ROCK‐dependent pathway Gwenola Le Dréan, Jean‐Vianney Haure‐Mirande, Laurent Ferrier, The FASEB Journal	2013	57
miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease Ben Readhead, Jean‐Vianney Haure‐Mirande, Diego Mastroeni, Acta Neuropathologica Neurodegenerative DiseasesAlzheimer's DiseaseMolecular NeuroscienceDementiaCortical Transcriptomics	2020	36
Transcriptomic Changes Highly Similar to Alzheimer’s Disease Are Observed in a Subpopulation of Individuals During Normal Brain Aging Shouneng Peng, Lu Zeng, Jean‐Vianney Haure‐Mirande, Frontiers in Aging Neuroscience Neurodegenerative DiseasesAlzheimer's DiseaseAgingNormal BrainLoad Development	2021	20

Page 1